The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...
Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...
The U.S. health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk’s Wegovy and ...
The US Food and Drug Administration found no increased risk of suicidal behavior or ideation linked to popular weight-loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback